Sponsor or institution
Clinical trials and research at Idt Biologika Gmbh
As of November 12, 2026, Find a Trial lists 12 NIH-funded research projects at this institution, with $9.8 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 12NIH research projects
NIH-funded research (12)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Developing new vaccines for infectious diseases and bioterrorism
This study is all about creating new vaccines to help protect people from infectious diseases, including those that could come from bioterrorism or drug-resistant germs, so that patients can have better options for staying healthy.
-
Creating master cell banks for new SARS-CoV-2 vaccines
This study is working on creating special cell banks to help make better vaccines for COVID-19, which could lead to more effective options for patients in the future.
-
Creating materials for testing new influenza vaccines
This study is working on creating and improving materials for new flu vaccines, which could help keep you and others safer from the flu and similar illnesses.
-
Creating master cell banks for new SARS-CoV-2 vaccines
This study is working on creating special cell banks to help make better vaccines for COVID-19, so that patients can have more effective protection against the virus and its variants.
-
Creating vaccines and biologics to combat infectious diseases
This study is working on creating new vaccines to help protect people from infections like those caused by E. coli, so that patients can have better options for staying healthy and safe from serious diseases.
-
Developing a vaccine for Staphylococcus aureus
This study is working on creating a new vaccine to help protect people from Staphylococcus aureus infections, which can be tough to treat because the bacteria resist many antibiotics, and it aims to make this vaccine safe and effective for future use.
-
Developing a vaccine using Vero cells for respiratory syncytial virus (RSV)
This study is working on making a safe and effective vaccine to protect babies and young kids from respiratory syncytial virus (RSV), which often causes breathing problems, by improving how the vaccine is produced.
-
Creating vaccines to combat E. coli and other infectious diseases
This study is working on creating new vaccines to help protect people from infections caused by E. coli, which could be especially helpful for patients looking for better ways to stay healthy and safe from serious illnesses.
-
Creating cell banks for vaccine production to prepare for pandemics
This study is all about creating and testing special cell banks that help make vaccines for infectious diseases, so we can be better prepared for future outbreaks and keep everyone safe.
-
Creating cell banks for vaccine development to prepare for pandemics
This study is all about creating special cell banks that help make vaccines quicker and safer for fighting infectious diseases and potential bioterrorism threats, so we can respond better to health emergencies.
-
Developing vaccines for infectious diseases including SARS-CoV-2
This study is working on creating and improving vaccines to help protect people from infectious diseases like COVID-19, and it aims to make new vaccines that could also fight against bioterrorism threats, so everyone can benefit from better protection in the future.
-
Developing a vaccine using Vero cells for respiratory syncytial virus (RSV).
This study is working on creating a new vaccine to help protect against respiratory syncytial virus (RSV) by improving how it's made, so it can be safely tested in people.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.